Literature DB >> 2172379

cAMP-independent effects of cholera toxin on B cell activation. I. A possible role for cell surface ganglioside GM1 in B cell activation.

M L Francis1, J Moss, T A Fitz, J J Mond.   

Abstract

Cholera toxin has been used as a tool to study the effects of cAMP on the activation of B cells but may have effects independent of its ability to elevate cAMP. We found five lines of evidence which suggested that cholera toxin suppressed mitogen-stimulated B cell activation through a cAMP-independent pathway. 1) Cholera toxin (1 microgram/ml) was consistently more suppressive than forskolin (100 microM) despite the induction of higher intracellular cAMP levels by forskolin. 2) Cholera toxin was more suppressive at 1 microgram/ml than at 0.1 microgram/ml despite equivalent elevations of cAMP. 3) Washing B cells following their incubation with cholera toxin reversed much of the inhibition without altering intracellular cAMP levels. 4) The A subunit of cholera toxin, which at high concentrations (10 micrograms/ml) induced levels of cAMP comparable to those induced by cholera toxin (1 and 0.1 microgram/ml), did not inhibit B cell activation. 5) cAMP derivatives at high concentrations were much less effective than was cholera toxin in suppressing B cell activation. Although the elevation of cAMP may cause a mild inhibition of B cell proliferation, we found that even a marked elevation of cAMP did not suppress B cell proliferation, unless the elevation was persistent. We did, however, observe that the degree of toxin inhibition more closely paralleled binding of the toxin to B cells than toxin stimulation of cAMP. This result raised the possibility that binding of cholera toxin to its ganglioside GM1 receptor mediated an inhibitory signal which suppressed B cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172379

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine.

Authors:  C Wennerås; A M Svennerholm; C Ahrén; C Czerkinsky
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

Review 2.  Molecular effects of cholera toxin on isotype differentiation.

Authors:  N Lycke; E Severinson; W Strober
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  The different inhibiting effect of cholera toxin on two leukemia cell lines does not correlate with their toxin binding capacity.

Authors:  A Giuliani; E Calappi; E Mineo; M G Neri; A Gallina; A Pessina
Journal:  Mol Cell Biochem       Date:  1995-11-22       Impact factor: 3.396

4.  Hemocyte-hemocyte adhesion and nodulation reactions of the greater wax moth, Galleria mellonella are influenced by cholera toxin and its B-subunit.

Authors:  Jason F Lapointe; Gary B Dunphy; Craig A Mandato
Journal:  Results Immunol       Date:  2012-02-25

5.  Escherichia coli heat-labile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological activities of the hybrid proteins.

Authors:  E K Jagusztyn-Krynicka; J E Clark-Curtiss; R Curtiss
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

6.  Characterization of hybrid toxins produced in Escherichia coli by assembly of A and B polypeptides from type I and type II heat-labile enterotoxins.

Authors:  T D Connell; R K Holmes
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.